Medicare Enrolled
Dr. Patrick Wirtz, M.D.
Urology Physician · Blue Ash, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wirtz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wirtz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wirtz
Dr. Patrick Wirtz is an urology physician in Blue Ash, OH, with 18 years of NPI registration. Based on federal Medicare data, Dr. Wirtz performed 4,880 Medicare services across 2,970 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wirtz received a total of $5,539 from 52 pharmaceutical and/or device companies across 296 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wirtz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 7% volume in OH
$5,539 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,880
Medicare services
Top 7% in OH for urology physician
2,970
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~271 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,101 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
797 | $84 | $248 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
746 | $3 | $25 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
426 | $8 | $32 |
| PSA test (prostate cancer screening) | 348 | $18 | $71 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
257 | $45 | $206 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
117 | $7 | $94 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
112 | $114 | $393 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
90 | $18 | $85 |
| Tumor marker analysis A laboratory test that analyzes a sample to detect the presence of tumor markers. These markers are substances that may be found in the blood, urine, or body tissues. |
89 | $20 | $51 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
84 | $57 | $626 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
71 | $8 | $51 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
59 | $24 | $312 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
44 | $25 | $101 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
40 | $8 | $39 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
36 | $96 | $1,272 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
36 | $5 | $37 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
35 | $127 | $315 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
34 | $91 | $536 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
30 | $8 | $28 |
| Blood urea nitrogen test A blood test that measures the amount of urea nitrogen to assess kidney function. |
30 | $4 | $29 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
29 | $99 | $318 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
28 | $18 | $71 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
27 | $39 | $112 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
26 | $52 | $351 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
24 | $8 | $105 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
24 | $8 | $105 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
23 | $14 | $152 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
22 | $116 | $1,761 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
20 | $76 | $407 |
| Complicated insertion of bladder tube | 16 | $110 | $429 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
13 | $65 | $279 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
12 | $185 | $826 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
12 | $6 | $14 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
11 | $137 | $427 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
11 | $62 | $149 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.2% high complexity
28.1% medium
70.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,539
Total received (2018-2024)
Avg $791/year across 7 years
Top 29% in OH for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
296
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,519 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$20 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$973
2023
$1,067
2022
$761
2021
$845
2020
$556
2019
$490
2018
$847
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$175
Sumitomo Pharma America, Inc.
$152
Merck Sharp & Dohme LLC
$107
UROGEN PHARMA, INC.
$86
Janssen Biotech, Inc.
$76
Dendreon Pharmaceuticals LLC
$54
Astellas Pharma US Inc
$48
ACCORD HEALTHCARE, INC.
$44
Ferring Pharmaceuticals Inc.
$42
IMMUNITYBIO, INC.
$37
Tolmar, Inc.
$33
PFIZER INC.
$32
SUN PHARMACEUTICAL INDUSTRIES INC.
$20
PROCEPT BioRobotics Corporation
$18
PROGENICS PHARMACEUTICALS, INC.
$17
Boston Scientific Corporation
$17
Verity Pharmaceuticals Inc.
$16
Top 3 companies account for 44.6% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$984
Janssen Biotech, Inc.
$681
PFIZER INC.
$319
Dendreon Pharmaceuticals LLC
$312
Sumitomo Pharma America, Inc.
$267
Teleflex LLC
$262
UroGen Pharma, Inc.
$255
NeoTract Inc.
$209
ABBVIE INC.
$175
Bayer HealthCare Pharmaceuticals Inc.
$165
Ferring Pharmaceuticals Inc.
$152
UROGEN PHARMA, INC.
$137
Merck Sharp & Dohme LLC
$135
Cook Medical LLC
$128
Axonics Modulation Technologies, Inc.
$127
COLOPLAST CORP
$117
AbbVie Inc.
$96
Blue Earth Diagnostics Limited
$93
ACCORD HEALTHCARE, INC.
$83
AbbVie, Inc.
$71
Merck Sharp & Dohme Corporation
$44
Myovant Sciences Inc.
$42
GENZYME CORPORATION
$40
Endo Pharmaceuticals Inc.
$38
SUN PHARMACEUTICAL INDUSTRIES INC.
$38
IMMUNITYBIO, INC.
$37
Boston Scientific Corporation
$36
Photocure Inc
$34
Tolmar, Inc.
$33
Calyxo, Inc.
$33
Axonics, Inc.
$30
E.R. Squibb & Sons, L.L.C.
$27
TOLMAR Pharmaceuticals, Inc.
$27
Coloplast Corp
$26
UROVANT SCIENCES INC
$25
Hollister Incorporated
$25
Bayer Healthcare Pharmaceuticals Inc.
$23
Foundation Medicine, Inc.
$19
Sun Pharmaceutical Industries Inc.
$18
PROCEPT BioRobotics Corporation
$18
PROGENICS PHARMACEUTICALS, INC.
$17
CONMED Corporation
$17
Verity Pharmaceuticals Inc.
$16
Clarus Therapeutics Inc.
$16
SANOFI-AVENTIS U.S. LLC
$15
Osiris Therapeutics Inc.
$15
Progenics Pharmaceuticals, Inc.
$14
Novartis Pharmaceuticals Corporation
$14
Antares Pharma, Inc.
$13
Aytu BioScience, Inc
$11
Janssen Pharmaceuticals, Inc
$9
Amniox Medical, Inc.
$4
Top 3 companies account for 35.8% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AIRSEAL · ANKTIVA · AQUABEAM SYSTEM · Androgel · Axonics · Axonics r-SNM System · Axumin · BOTOX · CAMCEVI · CLENPIQ · CONTINENCE CARE · COOK MEDICAL EXTRACTORS · CVAC · CYSVIEW · Cysview · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · JATENZO · JELMYTO · JEVTANA · KEYTRUDA · LithoVue · Lupron · MYRBETRIQ · Myrbetriq · NEOX · NOCDURNA · Natesto · Nubeqa · ORGOVYX · OTREXUP · Onli · PLUVICTO · PROVENGE · PYLARIFY · SpeediCath · Stravix · Trelstar · UROLIFT · UroLift · UroLift System · Veozah · XIAFLEX · XTANDI · Xofigo · Xtandi · YONSA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
85
Per 100K population
10.3
County median income
$70,816
Nearest hospital
BETHESDA NORTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wirtz is a clinical cardiology specialist, with above-average Medicare volume (top 7% in OH), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wirtz experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Wirtz performed 1,101 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wirtz receive payments from pharmaceutical companies?
Yes. Dr. Wirtz received a total of $5,539 from 52 companies across 296 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wirtz's costs compare to other urology physicians in Blue Ash?
Dr. Wirtz's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wirtz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Blue Ash
Browse urology physicians in Blue Ash ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in OH
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in OH
Which OH urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology